Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | CA6 | P23280 | 2/20 | 0.32 |
| ▸ | CA5A | P35218 | 2/20 | 0.32 |
| ▸ | CA7 | P43166 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.32 |
| ▸ | CA3 | P07451 | 1/20 | 0.32 |
| ▸ | CASP2 | P42575 | 2/20 | 0.31 |
| ▸ | F13A1 | P00488 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8850832 | 0.91 | TSHR (0.42) | CYP2C19MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL28111017 | 0.90 | HRH3 (0.39) | CYP2C19MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL28855173 | 0.89 | HRH3 (0.33) | CYP2C19MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL19214781 | 0.88 | TSHR (0.46) | CYP2C19MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL14163240 | 0.86 | CA12 (0.50) | CYP2C19MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL25989954 | 0.86 | TSHR (0.56) | CYP2C19ALDH1A1TSHRCYP1A2 | |
| SCHEMBL17965440 | 0.86 | CYP2C19 (0.48) | CYP2C19MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL22450950 | 0.86 | CYP2C19 (0.48) | CYP2C19MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL8510461 | 0.85 | ALDH1A1 (0.54) | ALDH1A1TSHR | |
| SCHEMBL3158951 | 0.85 | CA12 (0.48) | CYP2C19MEN1KMT2ATSHRGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1937235-A2 | METHODS FOR TREATING VIRAL INFECTIONS USING POLYAMINE ANALOGS | Pathologica, LLC. (US) | 2008-07-02 | — | — | EP | claimed |
| US-20070078187-A1 | METHODS FOR TREATING VIRAL INFECTIONS USING POLYAMINE ANALOGS | PATHOLOGICA, LLC. (US) | 2007-04-05 | — | — | US | claimed |
| WO-2007035957-A2 | METHODS FOR TREATING VIRAL INFECTIONS USING POLYAMINE ANALOGS | PATHOLOGICA, LLC. (US) | 2007-03-29 | — | — | WO | claimed |
| US-7087648-B1 | Methods for modulating macrophage proliferation using polyamine analogs | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-08-08 | — | — | US | claimed |
| US-20050159493-A1 | Methods for modulating macrophage proliferation using polyamine analogs | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2005-07-21 | — | — | US | claimed |
| JP-2001520990-A | — | — | 2001-11-06 | — | — | JP | claimed |
| EP-1027040-A2 | METHODS FOR MODULATING MACROPHAGE PROLIFERATION USING POLYAMINE ANALOGS | The Regents of the University of California (US) | 2000-08-16 | — | — | EP | claimed |
| WO-1999021542-A2 | METHODS FOR MODULATING MACROPHAGE PROLIFERATION USING POLYAMINE ANALOGS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-05-06 | — | — | WO | claimed |
| EP-3831372-A1 | MITOGUAZONE FOR PREVENTING THE RELAPSE OR THE PROGRESSION OF MULTIPLE SCLEROSIS | Pathologica LLC (US) | 2021-06-09 | — | — | EP | disclosed |
| US-20210085625-A1 | CONTROLLED RELEASE ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING MGBG | PATHOLOGICA LLC | 2021-03-25 | — | — | US | disclosed |
| US-10881626-B2 | Controlled release oral pharmaceutical dosage forms comprising MGBG | PATHOLOGICA LLC (US) | 2021-01-05 | — | — | US | disclosed |
| US-20190224144-A1 | METHOD OF TREATMENT WITH ANTI-INFLAMMATORY AND ANALGESIC COMPOUNDS WHICH ARE GI-, RENAL-, AND PLATELET-SPARING | PATHOLOGICA LLC | 2019-07-25 | — | — | US | disclosed |
| US-10350178-B2 | Methods and compositions for treatment of demyelinating diseases | PATHOLOGICA LLC (US) | 2019-07-16 | — | — | US | disclosed |
| US-10292950-B2 | Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing | PATHOLOGICA LLC (US) | 2019-05-21 | — | — | US | disclosed |
| US-20050256207-A1 | Methods for modulating macrophage proliferation in ocular disease using polyamine analogs | PROMAC TECHNOLOGIES, LLC | 2005-11-17 | — | — | US | disclosed |
| US-20050159493-A1 | Methods for modulating macrophage proliferation using polyamine analogs | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2005-07-21 | — | — | US | disclosed |
| US-20040224037-A1 | Devastating treatment against hiv/aids with capsaicin | ROMERO-MATOS GONZALO | 2004-11-11 | — | — | US | disclosed |
| US-20030175832-A1 | Methods for monitoring and treating amyotrophic lateral sclerosis | PATHOLOGICA, LLC | 2003-09-18 | — | — | US | disclosed |
| EP-1027040-A2 | METHODS FOR MODULATING MACROPHAGE PROLIFERATION USING POLYAMINE ANALOGS | The Regents of the University of California (US) | 2000-08-16 | — | — | EP | disclosed |
| WO-1999021542-A2 | METHODS FOR MODULATING MACROPHAGE PROLIFERATION USING POLYAMINE ANALOGS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256207-A1 | Methods for modulating macrophage proliferation in ocular disease using polyamine analogs | ARG1, CD209, CSF1R | CYP2C19 4803/4885MEN1 570/4885KMT2A 1148/4885 |
| US-20210085625-A1 | CONTROLLED RELEASE ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING MGBG | SHBG, UGGT1, GCG | CYP2C19 143/4885MEN1 974/4885KMT2A 4337/4885 |
| US-20070078187-A1 | METHODS FOR TREATING VIRAL INFECTIONS USING POLYAMINE ANALOGS | GLS, SHMT2, ARG2 | CYP2C19 3039/4885MEN1 446/4885KMT2A 1328/4885 |
| US-10881626-B2 | Controlled release oral pharmaceutical dosage forms comprising MGBG | SHBG, UGGT1, GCG | CYP2C19 143/4885MEN1 974/4885KMT2A 4337/4885 |
| US-20190224144-A1 | METHOD OF TREATMENT WITH ANTI-INFLAMMATORY AND ANALGESIC COMPOUNDS WHICH ARE GI-, RENAL-, AND PLATELET-SPARING | OPRK1, PTGES3, PTGES | CYP2C19 281/4885MEN1 4750/4885KMT2A 4558/4885 |
| US-20050159493-A1 | Methods for modulating macrophage proliferation using polyamine analogs | ARG1, MKI67, CSF1R | CYP2C19 4826/4885MEN1 865/4885KMT2A 209/4885 |
| US-10350178-B2 | Methods and compositions for treatment of demyelinating diseases | PMP22, MAG, GMFG | CYP2C19 4252/4885MEN1 2868/4885KMT2A 3249/4885 |
| US-10292950-B2 | Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing | OPRK1, PTGES3, PTGES | CYP2C19 281/4885MEN1 4750/4885KMT2A 4558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.